News Events Newsletter CerraCap Impact Venture Capital Appoints Former Silicon Valley Bank and Equifax CIO Mark Rohrwasser to Lead CXO Council June 1, 2026 Gemelli Biotech’s Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, Featured Across Multiple Research Presentations at DDW 2026 April 30, 2026 CerraCap Invests in Nephronomics to Advance AI-Driven Kidney Disease Discovery April 30, 2026 CerraCap Ventures and Impact Venture Capital Combine to Launch CerraCap Impact Venture Capital April 30, 2026 CerraCap Ventures Backs Enginius.ai to Revolutionize Engineering with AI September 16, 2025 Space Kinetic Raises $12-Million Seed Round for Space Missile Defense September 3, 2025 1 2 3 4 … 9
CerraCap Impact Venture Capital Appoints Former Silicon Valley Bank and Equifax CIO Mark Rohrwasser to Lead CXO Council
Gemelli Biotech’s Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, Featured Across Multiple Research Presentations at DDW 2026
